Alpha 2.0
Login Register
» Articles » PMID: 35016887

A Serendipitous Preoperative Trial of Combined Ipilimumab Plus Nivolumab for Localized Prostate Cancer

Overview
Journal Clin Genitourin Cancer
Publisher Elsevier
Specialties Oncology
Urology
Date 2022 Jan 12
PMID 35016887
Authors
Jeroen van Dorp
Maurits L van Montfoort
Nick van Dijk
Ingrid Hofland
Jeantine M de Feijter
Andries M Bergman
Kees Hendricksen
Henk G van der Poel
Bas W G van Rhijn
Michiel S van der Heijden
Affiliations
Soon will be listed here.
Citing Articles

Cyto-IL-15 synergizes with the STING agonist ADU-S100 to eliminate prostate tumors and confer durable immunity in mouse models.

Papaevangelou E, Esteves A, Dasgupta P, Galustian C Front Immunol. 2023; 14:1196829.

PMID: 37465665 PMC: 10350564. DOI: 10.3389/fimmu.2023.1196829.